Pro-Tumorigenic Effect of Continuous Cromolyn Treatment in Bladder Cancer.

Int J Mol Sci · 2025 · PMC11855506 · PMID 40004083

Europe PMC DOI

hedged sentence

0.0858

closest p · 1.7× alpha

0.0858

boldest claim

The sentences

showed a trendp = 0.0858so close (0.05 < p ≤ 0.1)

Our experiment with the administration of cromolyn after tumor formation also showed a trend in decreased tumor weight and volume, although with p = 0.0858.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.